203 related articles for article (PubMed ID: 19797858)
1. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice.
Beppu F; Niwano Y; Tsukui T; Hosokawa M; Miyashita K
J Toxicol Sci; 2009 Oct; 34(5):501-10. PubMed ID: 19797858
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH).
Beppu F; Niwano Y; Sato E; Kohno M; Tsukui T; Hosokawa M; Miyashita K
J Toxicol Sci; 2009 Dec; 34(6):693-8. PubMed ID: 19952505
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-glycolipid nanogels loaded with anti-obese marine carotenoid fucoxanthin: Acute and sub-acute toxicity evaluation in rodent model.
Ravi H; Arunkumar R; Baskaran V
J Biomater Appl; 2015 Oct; 30(4):420-34. PubMed ID: 26084499
[TBL] [Abstract][Full Text] [Related]
4. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice.
Hashimoto T; Ozaki Y; Taminato M; Das SK; Mizuno M; Yoshimura K; Maoka T; Kanazawa K
Br J Nutr; 2009 Jul; 102(2):242-8. PubMed ID: 19173766
[TBL] [Abstract][Full Text] [Related]
5. Nutraceutical characteristics of the brown seaweed carotenoid fucoxanthin.
Miyashita K; Beppu F; Hosokawa M; Liu X; Wang S
Arch Biochem Biophys; 2020 Jun; 686():108364. PubMed ID: 32315653
[TBL] [Abstract][Full Text] [Related]
6. Health-Promoting Functions of the Marine Carotenoid Fucoxanthin.
Hosokawa M
Adv Exp Med Biol; 2021; 1261():273-284. PubMed ID: 33783750
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic, Transcriptomic, and Protective Effect of Carotenoid Fucoxanthin in High Glucose-Induced Oxidative Stress in Mes13 Kidney Mesangial Cells.
Hudlikar RR; Sargsyan D; Li W; Wu R; Zheng M; Kong AN
Chem Res Toxicol; 2021 Mar; 34(3):713-722. PubMed ID: 33448797
[TBL] [Abstract][Full Text] [Related]
10. Fucoxantin: a treasure from the sea.
D'Orazio N; Gemello E; Gammone MA; De Girolamo M; Ficoneri C; Riccioni G
Mar Drugs; 2012 Mar; 10(3):604-616. PubMed ID: 22611357
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice.
Jeon SM; Kim HJ; Woo MN; Lee MK; Shin YC; Park YB; Choi MS
Biotechnol J; 2010 Sep; 5(9):961-9. PubMed ID: 20845386
[TBL] [Abstract][Full Text] [Related]
12. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study.
Mok IK; Lee JK; Kim JH; Pan CH; Kim SM
Food Chem; 2018 Aug; 258():79-86. PubMed ID: 29655757
[TBL] [Abstract][Full Text] [Related]
14. Isolation and Purification of Fucoxanthin from Brown Seaweed
Ye Y; Sun J; Wang L; Zhu J; Cui W; Hou H; Zhang J; Zhou C; Yan X
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206231
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation.
Zheng J; Tian X; Zhang W; Zheng P; Huang F; Ding G; Yang Z
Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31569771
[TBL] [Abstract][Full Text] [Related]
16. Keto-carotenoids are the major metabolites of dietary lutein and fucoxanthin in mouse tissues.
Yonekura L; Kobayashi M; Terasaki M; Nagao A
J Nutr; 2010 Oct; 140(10):1824-31. PubMed ID: 20739451
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-A(y) mice.
Beppu F; Hosokawa M; Niwano Y; Miyashita K
Lipids Health Dis; 2012 Sep; 11():112. PubMed ID: 22962999
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Fucoxanthin-Loaded Nanoparticles Composed of Casein and Chitosan with Improved Fucoxanthin Bioavailability.
Koo SY; Mok IK; Pan CH; Kim SM
J Agric Food Chem; 2016 Dec; 64(49):9428-9435. PubMed ID: 27960297
[TBL] [Abstract][Full Text] [Related]
19. [Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats].
Iio K; Okada Y; Ishikura M
Shokuhin Eiseigaku Zasshi; 2011; 52(3):183-9. PubMed ID: 21720124
[TBL] [Abstract][Full Text] [Related]
20. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice.
Terasaki M; Uehara O; Ogasa S; Sano T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
Carcinogenesis; 2021 Feb; 42(2):210-219. PubMed ID: 32940665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
